Huron (HURN) Q1 2026 Earnings Call Transcript

Huron Consulting Group delivered Q1 RBR of $443.7 million, up 12.1%, with adjusted EBITDA rising to $50.6 million and margins improving to 11.4% of RBR. Management reaffirmed full-year 2026 guidance for $1.78 billion-$1.86 billion of RBR, 14.5%-15% adjusted EBITDA margin, and $8.35-$9.15 adjusted EPS, while bookings rose more than 20% across all segments and pipelines remained near record levels. Free cash flow was negative $174.1 million in the quarter due to incentive payments and buybacks, but the company reiterated positive full-year free cash flow and a lower leverage target by year-end.

Analysis

The key signal is not just that demand is healthy, but that HURN is converting backlog into a larger, higher-quality mix of recurring/managed-service work. That matters because the company is effectively lowering earnings volatility: managed services and longer-duration health care programs should smooth utilization and improve visibility, even if cash conversion lags temporarily from milestone billing and incentive payouts.

The market is likely underappreciating the asymmetry between near-term cash flow noise and medium-term EPS compounding. The quarter’s leverage spike and negative FCF are mechanically tied to seasonality plus accelerated buybacks, not operational stress; if management executes on even partial normalization of DSO and capex while continuing repurchases at a slower pace, EPS can outgrow EBITDA through denominator shrink. That creates a second-order effect: lower share count can offset a good chunk of any moderation in organic growth next year.

The real optionality is AI monetization layered on top of an already embedded digital base. The consensus may be treating AI as a vague narrative, but for HURN it is likely a margin tool first and a revenue accelerator second: internal deployment improves delivery economics, while client-facing use cases deepen wallet share in consulting and managed services. The contrarian risk is that the stock is now more sensitive to any slip in health care utilization or a pause in buybacks, since the valuation case is increasingly built on sustained capital returns plus steady backlog conversion rather than explosive organic growth.

Key Decisions for Investors

• Long HURN on pullbacks over the next 2-6 weeks; target a 12-15% total return if guidance credibility plus buyback support continue, with a stop if backlog conversion or margin expansion stalls for two consecutive quarters.
• Buy HURN Jan-2027 call spreads to express the view that share count reduction and AI-led margin gains drive upside beyond near-term cash flow noise; risk/reward improves if implied volatility remains elevated after the print.
• Pair trade: long HURN / short a slower-growing IT consulting comp basket over 3-6 months, betting HURN’s managed-services mix and repurchases produce faster EPS accretion than peers with similar top-line growth.
• If already long, sell near-dated covered calls against HURN into strength; the main near-term catalyst is rerating on guidance reaffirmation, while the near-term downside is mostly from working-capital optics rather than fundamentals.